The study is to evaluate the efficacy and safety of evobrutinib administered orally twice ...
The study is to evaluate the efficacy and safety of evobrutinib administered orally twice ...
To assess safety and tolerability of patients converting from approved Relapsing Multiple ...
To determine the long-term (approximately 2 years) nephroprotective potential of treatment ...
Research is making important progress in understanding how Alzheimer's disease affects the brain, and a number of potential therapies are in clinical development.
Learn more about Alzheimer's disease
Join our Alzheimer's disease community
Diabetes is increasing worldwide at epidemic rates. However, the research pipeline holds a number of potential medicines for both type 1 and type 2 diabetes.
Register to get notifications about clinical trials in your area.
Register to Receive UpdatesRecent medical advances have changed how we treat lupus, but there are still unmet needs. A number of potential medications are undergoing clinical research.
Therapy for multiple sclerosis has made great strides over the past 15 years. However, there is still no known cure for multiple sclerosis, making ongoing clinical research imperative.
Learn more about multiple sclerosis
Join our multiple sclerosis community
There is still no known cure for NASH. However, several potential medicines are undergoing clinical research, and there are many opportunities to join clinical trials.
English (USA)
